Autoimmune Diseases  >>  Exubera (recombinant human insulin inhalational)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Exubera (recombinant human insulin inhalational) / Nektar Therap
NCT00527397: Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes

Terminated
3
24
Japan
CP-464,005, Exubera
Pfizer
Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
07/08
07/08
NCT00137046: Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes

Terminated
3
582
US, Canada, RoW
Subcutaneous Insulin, Inhaled Insulin
Pfizer
Diabetes Mellitus, Type 1
12/08
12/08

Download Options